⌕

Argen X (ARGX) vs Teva- Pharmaceutical Industries (TEVA)

Your goal
● Balanced style: every factor counts equally.
#1 FIT · LEADS
74
Argen X SE
$960.04 · $59B · as of last close
Strongest balance sheetFastest growerHighest quality
of the stocks compared here

The front-runner. Leads the balanced score. Its widest win over the field is balance sheet.

#2 FIT
47
Teva- Pharmaceutical Industries Ltd.
$44.50 · $52B · as of last close

The challenger. Trails the leader on the balanced score. Its widest win over the field is valuation.

ARGX leads clearly (74/100 vs TEVA 47) under a balanced style, mostly on balance sheet. But TEVA wins on valuation, so the comparison turns on what you weight. Switch your goal above and watch the scores move.

THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal

FactorARGXTEVA
Overall fit score
weighted for your balanced goal
✓ 74
47
5 of 8 factors known
Valuation
Cheaper for what you get
1×
P/E 46 · EV/EBITDA 53.5
P/E fiscal 2025
15
✓ P/E 104 · EV/EBITDA 26.7
P/E trailing
24
P/E bases differ: fiscal 2025 for ARGX, trailing for TEVA.
Growth
Revenue & earnings momentum
1×
✓ —
99
—
50
Profitability & quality
Margins & return on capital
1×
✓ Net 30% · ROIC 100%
fiscal 2025
94
Net 3% · ROIC 6%
TTM through Sep 30, 2026
56
Total return
Share-price change with dividends reinvested
1×
✓ 5Y +25%/yr
87
—
—
Risk (calm = better)
Volatility & drawdown
1×
✓ β 0.5 · DD −38%
83
β —
—
Balance sheet†
Debt vs cash cushion
1×
✓ Net debt/EBITDA −3.0×
fiscal 2025
77
Net debt/EBITDA 5.2×
TTM through Sep 30, 2026
6
Dividend & income
Cash paid to you
1×
✓ —
40
—
—
Analyst sentiment
Forward EPS growth (consensus)
1×
✓ Est EPS +36%/yr · 9 analysts
100
✓ Est EPS +52%/yr · 9 analysts
100
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
Loading chart…
WHERE EACH ONE IS STRONG
GrowthValueQuality
Return & Safety & Income axis omitted: no data for one of these stocks.
■ ARGX■ TEVA
CAN YOU STOMACH THE RIDE?
Worst drawdown3-year beta vs S&P 500VolatilityHistory
ARGX−38%0.5540%5Y
TEVA———0.1Y
Drawdown and volatility are measured over five years on the same total return as the chart, dividends reinvested.
THE CASE FOR & AGAINST EACH
BULL CASE

▲ Leads on balance sheet (score 77). Net debt/EBITDA −3.0× is one of the 5 inputs.

▲ Leads on growth: — (score 99).

BEAR CASE

▼ Weakest on valuation: P/E 46 · EV/EBITDA 53.5 (score 15).

BULL CASE

▲ Best factor is analyst sentiment: Est EPS +52%/yr · 9 analysts (score 100).

BEAR CASE

▼ Weakest on balance sheet (score 6). Net debt/EBITDA 5.2× is one of the 5 inputs.

▼ Weakest on growth: — (score 50).

WHAT COULD CHANGE THE SCORE
ValuationCurrently 15/100 (P/E 46 · EV/EBITDA 53.5). Taking it to 100 would lift the balanced score by 11 points, the biggest single move available.
Dividend & incomeCurrently 40/100 (—). Taking it to 100 would lift the balanced score by 8 points, the next biggest.
Balance sheetCurrently 6/100 (Net debt/EBITDA 5.2×). Taking it to 100 would lift the balanced score by 19 points, the biggest single move available.
ValuationCurrently 24/100 (P/E 104 · EV/EBITDA 26.7). Taking it to 100 would lift the balanced score by 15 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 13, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.